• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SCHEDULE 13G filed by DocGo Inc.

    4/30/25 10:53:25 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care
    Get the next $DCGO alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    DocGo Inc

    (Name of Issuer)


    Common Stock

    (Title of Class of Securities)


    256086109

    (CUSIP Number)


    03/31/2025

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    256086109


    1Names of Reporting Persons

    The Vanguard Group
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    PENNSYLVANIA
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    54,316.00
    7Sole Dispositive Power

    5,379,886.00
    8Shared Dispositive Power

    89,342.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    5,469,228.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.36 %
    12Type of Reporting Person (See Instructions)

    IA


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    DocGo Inc
    (b)Address of issuer's principal executive offices:

    35 West 35th Street, Floor 6, New York, NY, 10001
    Item 2. 
    (a)Name of person filing:

    The Vanguard Group
    (b)Address or principal business office or, if none, residence:

    100 Vanguard Blvd., Malvern, PA 19355
    (c)Citizenship:

    PA
    (d)Title of class of securities:

    Common Stock
    (e)CUSIP No.:

    256086109
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox not checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    5469228
    (b)Percent of class:

    5.36  %
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    0

     (ii) Shared power to vote or to direct the vote:

    54316

     (iii) Sole power to dispose or to direct the disposition of:

    5379886

     (iv) Shared power to dispose or to direct the disposition of:

    89342

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.


    The Vanguard Group, Inc.'s clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein. No one other person's interest in the securities reported herein is more than 5%.
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    Not Applicable
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    The Vanguard Group
     
    Signature:Ashley Grim
    Name/Title:Head of Global Fund Administration
    Date:04/30/2025
    Get the next $DCGO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DCGO

    DatePrice TargetRatingAnalyst
    5/9/2025Buy → Neutral
    BTIG Research
    2/28/2025$5.00 → $2.85Buy → Hold
    Deutsche Bank
    8/18/2023$15.00Buy
    BTIG Research
    4/21/2023$11.00Overweight
    Cantor Fitzgerald
    4/19/2022$11.00Buy
    Deutsche Bank
    1/19/2022$14.00Buy
    Stifel
    12/21/2021$13.00Buy
    Canaccord Genuity
    12/7/2021$14.00Buy
    Needham
    More analyst ratings

    $DCGO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Burdiek Michael J bought $13,300 worth of shares (10,000 units at $1.33), increasing direct ownership by 2% to 641,560 units (SEC Form 4)

    4 - DocGo Inc. (0001822359) (Issuer)

    5/23/25 4:25:30 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    Director Burdiek Michael J bought $21,450 worth of shares (15,000 units at $1.43), increasing direct ownership by 2% to 631,560 units (SEC Form 4)

    4 - DocGo Inc. (0001822359) (Issuer)

    5/15/25 5:05:47 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    Director Klasko Stephen K. M.D. bought $22,350 worth of shares (15,000 units at $1.49) (SEC Form 4)

    4 - DocGo Inc. (0001822359) (Issuer)

    5/14/25 5:42:40 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    $DCGO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    DocGo Announces Participation at Upcoming December Investor Conferences

    DocGo Inc. (NASDAQ:DCGO) ("DocGo"), a leading provider of technology-enabled mobile health and medical transportation services, announced today that management will be participating in the following investor conferences in December: Noble Capital Markets Emerging Growth Conference (December 3rd) Lee Bienstock, Chief Executive Officer will participate in 1x1 meetings and deliver a presentation on Wednesday, December 3rd at 1:00 PM ET. A webcast of the event will be available on the investor relations section of DocGo's website at https://ir.docgo.com/. Citi's 2025 Global Healthcare Conference (December 4th) Lee Bienstock, Chief Executive Officer will participate in 1x1 meetings at this eve

    11/26/25 7:35:00 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    DocGo Announces Participation at Upcoming Investor Conferences

    DocGo Inc. (NASDAQ:DCGO) ("DocGo"), a leading provider of technology-enabled mobile health and medical transportation services, announced today that management will be participating in the following investor conferences in November: 17th Annual Southwest Ideas Conference (November 19th) Norm Rosenberg, Chief Financial Officer will participate in 1x1 meetings and deliver a presentation on Wednesday November 19th at 2:20 PM ET. A webcast of the event will be available on the investor relations section of DocGo's website at https://ir.docgo.com/. Canaccord Genuity Medtech, Diagnostics and Digital Health & Services Forum (November 20st) Lee Bienstock, Chief Executive Officer, and Norm Rosen

    11/13/25 7:35:00 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    DocGo Announces Third Quarter 2025 Results

    Company Achieves Record Volumes Across All Major Business Lines Management to Host Conference Call and Webcast Today at 5:00 PM Eastern Time DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial and operating results for the quarter ended September 30, 2025. Third Quarter 2025 Financial Highlights Total revenue for the third quarter of 2025 was $70.8 million, compared to $138.7 million in the third quarter of 2024. This decline was entirely due to the wind-down of migrant-related programs, which generated $8.4 million in the third quarter of 2025 and $80.7 million in

    11/10/25 4:05:00 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    $DCGO
    SEC Filings

    View All

    DocGo Inc. filed SEC Form 8-K: Regulation FD Disclosure

    8-K - DocGo Inc. (0001822359) (Filer)

    12/12/25 4:08:48 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    SEC Form 10-Q filed by DocGo Inc.

    10-Q - DocGo Inc. (0001822359) (Filer)

    11/10/25 4:39:05 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    DocGo Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - DocGo Inc. (0001822359) (Filer)

    11/10/25 4:07:42 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    $DCGO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Klasko Stephen K. M.D. was granted 100,000 shares, increasing direct ownership by 667% to 115,000 units (SEC Form 4)

    4 - DocGo Inc. (0001822359) (Issuer)

    9/11/25 5:20:13 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    Chief Compliance Officer Sugrue Stephen covered exercise/tax liability with 5,813 shares, decreasing direct ownership by 2% to 351,515 units (SEC Form 4)

    4 - DocGo Inc. (0001822359) (Issuer)

    7/2/25 4:34:23 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    CFO and Treasurer Rosenberg Norman covered exercise/tax liability with 11,332 shares, decreasing direct ownership by 1% to 859,940 units (SEC Form 4)

    4 - DocGo Inc. (0001822359) (Issuer)

    7/2/25 4:33:28 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    $DCGO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    DocGo downgraded by BTIG Research

    BTIG Research downgraded DocGo from Buy to Neutral

    5/9/25 8:41:42 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    DocGo downgraded by Deutsche Bank with a new price target

    Deutsche Bank downgraded DocGo from Buy to Hold and set a new price target of $2.85 from $5.00 previously

    2/28/25 8:51:46 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    BTIG Research initiated coverage on DocGo with a new price target

    BTIG Research initiated coverage of DocGo with a rating of Buy and set a new price target of $15.00

    8/18/23 7:24:03 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    $DCGO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by DocGo Inc.

    SC 13D/A - DocGo Inc. (0001822359) (Subject)

    11/29/24 4:14:57 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by DocGo Inc.

    SC 13G/A - DocGo Inc. (0001822359) (Subject)

    11/14/24 9:56:36 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G/A filed by DocGo Inc. (Amendment)

    SC 13G/A - DocGo Inc. (0001822359) (Subject)

    3/1/24 4:53:15 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    $DCGO
    Financials

    Live finance-specific insights

    View All

    DocGo Announces Third Quarter 2025 Results

    Company Achieves Record Volumes Across All Major Business Lines Management to Host Conference Call and Webcast Today at 5:00 PM Eastern Time DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial and operating results for the quarter ended September 30, 2025. Third Quarter 2025 Financial Highlights Total revenue for the third quarter of 2025 was $70.8 million, compared to $138.7 million in the third quarter of 2024. This decline was entirely due to the wind-down of migrant-related programs, which generated $8.4 million in the third quarter of 2025 and $80.7 million in

    11/10/25 4:05:00 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    DocGo to Announce Third Quarter 2025 Results on Monday, November 10, 2025

    Management to host conference call and webcast at 5:00 p.m. ET on that day DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health and medical transportation services, announced today that the Company will release its financial results for the third quarter ended September 30, 2025 after the markets close on Monday, November 10, 2025. Management will also host a conference call to discuss these results at 5:00 p.m. ET on that day. Conference call and webcast details: Monday, November 10, 2025 5:00 p.m. ET 1-800-717-1738 (U.S.) 1-646-307-1865 (international) Conference ID: 87106 To access the Call me™ feature, which avoids the nee

    10/27/25 7:35:00 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    DocGo Acquires Virtual Care Platform SteadyMD, Expands Telehealth Services Across All 50 States

    Strategic Acquisition Combines DocGo's Last Mile Healthcare Delivery Capabilities With SteadyMD's Virtual Care Platform; SteadyMD Is Expected To Generate Approximately $25 Million in Revenue in 2025* DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health and medical transportation services, today announced that it has acquired virtual care platform SteadyMD, Inc. Management will host a conference call and webcast on Tuesday, October 21 at 11:00 a.m. ET to discuss this acquisition. SteadyMD powers high-quality telehealth experiences for digital health companies, labs, pharmacies, employers, and other healthcare innovators. The company

    10/20/25 5:21:00 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    $DCGO
    Leadership Updates

    Live Leadership Updates

    View All

    DocGo Acquires PTI Health To Expand Proactive Healthcare Offering with Mobile Lab Collection and Mobile Phlebotomy Services

    DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, today announced the acquisition of PTI Health, a mid-Atlantic mobile lab collection and phlebotomy services company. This strategic move expands DocGo's healthcare service offering to include mobile phlebotomy lab services, addressing critical gaps in diagnostic care for underserved populations. With this acquisition, DocGo will facilitate timely, convenient blood collection and additional at-home testing services for patients, offering a new level of care to those with limited access to traditional labs or transportation options. The acquisition enhances DocGo's offerings

    2/10/25 7:35:00 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    DocGo Appoints Healthcare Visionary Dr. Stephen K. Klasko as Chair of the Board

    DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, today announced the appointment of Stephen K. Klasko, M.D., M.B.A as the new independent, non-executive Chair of its Board of Directors, effective October 1, 2024. Dr. Klasko has an extensive background in leadership roles within healthcare, higher education and medical industry innovation, including an eight-year tenure as the President of Thomas Jefferson University and the CEO of Jefferson Health where he oversaw its expansion to 18 hospitals and over 35,000 employees. Prior to that, he was CEO of USF Health and Dean of the Morsani College of Medicine at the University o

    9/30/24 7:35:00 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    DocGo Appoints Eiwe Lingefors as New Chief Information Officer

    DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-driven healthcare solutions, is proud to announce Eiwe Lingefors as Chief Information Officer (CIO). Lingefors most recently served as the company's Chief Information Security Officer, and will continue in this role as well. In his new role as CIO, Lingefors will lead both DocGo's information security and digital innovation strategy in an evolving cybersecurity landscape. "Eiwe has been a vital part of our team, and his deep expertise in the security landscape has been instrumental in DocGo's operations," said Lee Bienstock, CEO of DocGo. "He has done an excellent job strengthening DocGo's existing cybers

    9/26/24 7:35:00 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care